首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel pentamidine derivatives: synthesis, anti-tumor properties and polynucleotide-binding activities.
【24h】

Novel pentamidine derivatives: synthesis, anti-tumor properties and polynucleotide-binding activities.

机译:新型喷他idine衍生物:合成,抗肿瘤性质和多核苷酸结合活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Novel amidino-substituted conformationally restricted derivatives of pentamidine were synthesized and their antiproliferative activity against several human cancer cell lines determined. It was found that introduction of furandicarboxamide core moiety (9, 10) increases antiproliferative activity as well as selectivity against certain tumor cell lines in comparison with amidino-substituted furan-mono-carboxamide (5, 6). Unlike the furan series where iso-propyl substituted amidine (10) exhibits more potent overall antiproliferative activity and selectivity toward certain cell lines, the same was found for unsubstituted amidines in pyridine series. Amongst all tested compounds the compound 10 is the only one that possesses antiproliferative activity against SW 620 cell line (4 muM). Spectroscopic studies of the interactions of prepared diamidines with double-stranded DNA and RNA polynucleotides show that all compounds preferentially bind into the minor groove of DNA, while most of them intercalate into RNA. The structure-dependant biological activity and the lack of DNA/RNA selective binding suggest that the mechanism of action of the here-presented compounds is controlled not only by the interactions with cellular nucleic acids, but also with other more specific protein targets.
机译:合成了pen胺的新型a基取代的构象受限衍生物,并确定了它们对几种人类癌细胞系的抗增殖活性。已经发现,与a基取代的呋喃-单甲酰胺(5,6)相比,呋喃二甲酰胺核心部分(9,10)的引入增加了抗增殖活性以及对某些肿瘤细胞系的选择性。与呋喃系列不同,在呋喃系列中,异丙基取代的idine(10)对某些细胞系表现出更强的总体抗增殖活性和选择性,在吡啶系列中,未取代的idine具有相同的活性。在所有测试的化合物中,化合物10是唯一对SW 620细胞系(4μM)具有抗增殖活性的化合物。制备的二am与双链DNA和RNA多核苷酸相互作用的光谱研究表明,所有化合物都优先结合到DNA的小沟中,而大多数化合物都插入RNA中。依赖结构的生物学活性和缺乏DNA / RNA选择性结合表明,本文提出的化合物的作用机理不仅受与细胞核酸的相互作用控制,而且还受与其他更具体的蛋白质靶标的相互作用控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号